10-K Filing

GUIDED THERAPEUTICS INC CIK: 924515 FY 2016

Filing Information

Form Type	10-K
Accession Number	`0001654954-17-002258`
Period End Date	20161231
Filing Date	20170322
Fiscal Year	2016
Fiscal Period	FY
XBRL Instance	gthp-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 87 Income Statement 42 Cash Flow Statement 69 Stockholders Equity 27

Balance Sheet 87 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$279.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$95.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$278.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$118.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $279 and $95 at December 31, 2016 and 2015, respectively	`AccountsReceivableNet`	$190.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $279 and $95 at December 31, 2016 and 2015, respectively	`AccountsReceivableNet`	-	USD	Point-in-time
Series C convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory, net of reserves of $278 and $118 at December 31, 2016 and 2015, respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$1.12M	USD	Point-in-time
Inventory, net of reserves of $278 and $118 at December 31, 2016 and 2015, respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$773.00K	USD	Point-in-time
Series C convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$259.00K	USD	Point-in-time
Series C convertible preferred stock, authorized	`PreferredStockSharesAuthorized`	9.00	shares	Point-in-time
Series C convertible preferred stock, authorized	`PreferredStockSharesAuthorized`	9.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$780.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.12M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.05M	USD	Point-in-time
Series C convertible preferred stock, issued	`PreferredStockSharesIssued`	5.60	shares	Point-in-time
Series C convertible preferred stock, issued	`PreferredStockSharesIssued`	1.60	shares	Point-in-time
Series C convertible preferred stock, outstanding	`PreferredStockSharesOutstanding`	5.60	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$126.00K	USD	Point-in-time
Series C convertible preferred stock, outstanding	`PreferredStockSharesOutstanding`	1.60	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$318.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$320.00K	USD	Point-in-time
Series C convertible preferred stock, liquidation preference	`PreferredStockLiquidationPreferenceValue`	$5.55M	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$73.00K	USD	Point-in-time
Series C convertible preferred stock, liquidation preference	`PreferredStockLiquidationPreferenceValue`	$1.64M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$391.00K	USD	Point-in-time
Series C1 convertible preferred stock, par value	`SeriesC1PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series C1 convertible preferred stock, par value	`SeriesC1PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$446.00K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.49M	USD	Point-in-time
Series C1 convertible preferred stock, authorized	`SeriesC1PreferredStockSharesAuthorized`	20.30	shares	Point-in-time
TOTAL ASSETS	`Assets`	$2.52M	USD	Point-in-time
Series C1 convertible preferred stock, authorized	`SeriesC1PreferredStockSharesAuthorized`	20.30	shares	Point-in-time
Series C1 convertible preferred stock, issued	`SeriesC1PreferredStockSharesIssued`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, issued	`SeriesC1PreferredStockSharesIssued`	0.00	shares	Point-in-time
Series C1 convertible preferred stock, outstanding	`SeriesC1PreferredStockSharesOutstanding`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, outstanding	`SeriesC1PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Series C1 convertible preferred stock, liquidation preference	`SeriesC1PreferredStockLiquidationPreferenceValue`	-	USD	Point-in-time
Notes payable in default, including related parties	`ShortTermBorrowings`	$133.00K	USD	Point-in-time
Series C1 convertible preferred stock, liquidation preference	`SeriesC1PreferredStockLiquidationPreferenceValue`	$4.31M	USD	Point-in-time
Notes payable in default, including related parties	`ShortTermBorrowings`	$1.01M	USD	Point-in-time
Short-term note payable	`ShorttermNotesPayable`	$197.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term note payable	`ShorttermNotesPayable`	$704.00K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	$2.36M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Short-term convertible notes payable, net	`NotesPayableCurrent`	$468.00K	USD	Point-in-time
Short-term convertible notes payable, net	`NotesPayableCurrent`	$686.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	669.00	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	3.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	3.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	669.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.82M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.91M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$2.67M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$34.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$217.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.34M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.47M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$2.61M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.42M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$8.08M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$10.76M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 1.6 and 5.6 shares issued and outstanding as of December 31, 2016 and 2015, respectively. (Liquidation preference of $1,643 and $5,555 at December 31, 2016 and 2015, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$601.00K	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 1.6 and 5.6 shares issued and outstanding as of December 31, 2016 and 2015, respectively. (Liquidation preference of $1,643 and $5,555 at December 31, 2016 and 2015, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$2.05M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 5.6 shares issued and outstanding as of December 31, 2015 and none authorized or issued and outstanding at December 31, 2014. (Liquidation preference of $5,555 at December 31, 2015 and none at December 31, 2014).	`ConvertiblePreferredStockSeriesC1NonredeemableOrRedeemableIssuerOptionValue`	$701.00K	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 5.6 shares issued and outstanding as of December 31, 2015 and none authorized or issued and outstanding at December 31, 2014. (Liquidation preference of $5,555 at December 31, 2015 and none at December 31, 2014).	`ConvertiblePreferredStockSeriesC1NonredeemableOrRedeemableIssuerOptionValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000 shares authorized, 669 and 3 shares issued and outstanding as of December 31, 2016 and 2015, respectively	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000 shares authorized, 669 and 3 shares issued and outstanding as of December 31, 2016 and 2015, respectively	`CommonStockValue`	$236.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$116.38M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$114.84M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-122.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-127.56M	USD	Point-in-time
TOTAL STOCKHOLDERS DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.27M	USD	Point-in-time
TOTAL STOCKHOLDERS DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-5.56M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$2.52M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$1.49M	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`SalesDevicesAndDisposables`	$564.00K	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$605.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$537.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$493.00K	USD	Annual
Gross Profit (loss)	`GrossProfit`	$27.00K	USD	Annual
Gross Profit (loss)	`GrossProfit`	$112.00K	USD	Annual
Contract and grant revenue	`Revenues`	-	USD	Annual
Contract and grant revenue	`Revenues`	$42.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$733.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.48M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$718.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$393.00K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.81M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$4.10M	USD	Annual
Total operating expenses	`OperatingExpenses`	$3.93M	USD	Annual
Total operating expenses	`OperatingExpenses`	$6.30M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-6.23M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.82M	USD	Annual
Other income	`OtherIncome`	$74.00K	USD	Annual
Other income	`OtherIncome`	$68.00K	USD	Annual
Interest expense	`InterestExpense`	$1.90M	USD	Annual
Interest expense	`InterestExpense`	$1.32M	USD	Annual
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$568.00K	USD	Annual
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$1.68M	USD	Annual
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-675.00K	USD	Annual
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-150.00K	USD	Annual
LOSS FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.97M	USD	Annual
LOSS FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.90M	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
NET LOSS	`NetIncomeLoss`	$-3.97M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-6.90M	USD	Annual
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	$1.26M	USD	Annual
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	-	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$1.02M	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$1.34M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.00M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.50M	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-5.94K	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-24.62	USD	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	2.00	shares	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	203.00	shares	Annual

Cash Flow Statement 69 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.97M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.90M	USD	Annual
Bad debt expense	`ProvisionForDoubtfulAccounts`	$19.00K	USD	Annual
Bad debt expense	`ProvisionForDoubtfulAccounts`	$221.00K	USD	Annual
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.05M	USD	Annual
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.22M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.01M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$95.00K	USD	Annual
Non-employee stock based compensation	`NonemployeeShareBasedCompensation`	-	USD	Annual
Non-employee stock based compensation	`NonemployeeShareBasedCompensation`	$400.00K	USD	Annual
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$-568.00K	USD	Annual
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$-1.68M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$31.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-61.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-129.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-345.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-519.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$681.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$247.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-28.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$91.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$775.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-183.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$193.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.12M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.13M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$2.17M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$2.86M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.80M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-4.04M	USD	Annual
Additions to fixed assets	`PaymentsToAcquireProductiveAssets`	-	USD	Annual
Additions to fixed assets	`PaymentsToAcquireProductiveAssets`	$8.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net proceeds from issuance of preferred stock and warrants, net	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	Annual
Net proceeds from issuance of preferred stock and warrants, net	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$3.70M	USD	Annual
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromIssuanceOfCommonStock`	$720.00K	USD	Annual
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromIssuanceOfCommonStock`	$50.00K	USD	Annual
Proceeds from debt financing, net of discount and debt issuance costs	`ProceedsFromIssuanceOfDebt`	$377.00K	USD	Annual
Proceeds from debt financing, net of discount and debt issuance costs	`ProceedsFromIssuanceOfDebt`	$1.96M	USD	Annual
Payments on notes	`PaymentsOfLoanCosts`	$227.00K	USD	Annual
Payments on notes	`PaymentsOfLoanCosts`	$1.01M	USD	Annual
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$143.00K	USD	Annual
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.78M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.92M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-21.00K	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-127.00K	USD	Annual
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of year	`Cash`	$14.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of year	`Cash`	$35.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$76.00K	USD	Annual
Cash paid for Interest	`InterestPaid`	-	USD	Annual
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$1.01M	USD	Annual
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$258.00K	USD	Annual
Dividends on preferred stock	`DividendsOnPreferredStock`	$1.34M	USD	Annual
Dividends on preferred stock	`DividendsOnPreferredStock`	$1.02M	USD	Annual
Deemed dividend on December 2014 public offering warrants	`DeemedDividendPublicOfferingWarrants`	$1.05M	USD	Annual
Deemed dividend on December 2014 public offering warrants	`DeemedDividendPublicOfferingWarrants`	-	USD	Annual
Term changes on Series B preferred stock and December 2014 public offering warrant resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockPublicOfferingWarrant`	$324.00K	USD	Annual
Term changes on Series B preferred stock and December 2014 public offering warrant resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockPublicOfferingWarrant`	-	USD	Annual
Repayment of deferred compensation via issuance of preferred stock	`RepaymentOfDeferredCompensationViaIssuanceOfPreferredStock`	$100.00K	USD	Annual
Repayment of deferred compensation via issuance of preferred stock	`RepaymentOfDeferredCompensationViaIssuanceOfPreferredStock`	-	USD	Annual
Deemed dividend on beneficial conversion features of Series C Preferred stock	`DeemedDividendOnBeneficialConversionFeaturesOfSeriesCPreferredStock`	$150.00K	USD	Annual
Deemed dividend on beneficial conversion features of Series C Preferred stock	`DeemedDividendOnBeneficialConversionFeaturesOfSeriesCPreferredStock`	-	USD	Annual
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	-	USD	Annual
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	$64.00K	USD	Annual

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$-4.46M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-5.56M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-9.27M	USD	Point-in-time
Preferred dividends	`DividendsPreferredStock`	$-352.00K	USD	Annual
Preferred dividends	`DividendsPreferredStock`	$-191.00K	USD	Annual
Issuance of common stock from accrued dividends, Shares	`IssuanceOfCommonStockFromAccruedDividendsShares`	54.00	shares	Annual
Issuance of common stock from accrued dividends, Shares	`IssuanceOfCommonStockFromAccruedDividendsShares`	54.00	shares	Annual
Conversion of Series C preferred stock to common stock, Amount	`ConversionOfSeriesCPreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series C preferred stock to common stock, Amount	`ConversionOfSeriesCPreferredStockToCommonStockAmount`	-	USD	Annual
Issuance of common stock and warrants, Amount	`IssuanceOfCommonStockAndWarrants`	$1.34M	USD	Annual
Exercise of warrants and options for common stock, Amount	`ExerciseOfWarrantsAndOptionsForCommonStockAmount`	$143.00K	USD	Annual
Conversion of debt into common stock, Amount	`DebtConversionConvertedInstrumentAmount1`	$258.00K	USD	Annual
Conversion of debt into common stock, Amount	`DebtConversionConvertedInstrumentAmount1`	$1.01M	USD	Annual
Issuance of common stock due to Series B, Tranche B warrants exchanged for shares and rights to shares, Amount	`IssuanceOfCommonStockDueToSeriesBTrancheBWarrantsExchangedForSharesAndRightsToSharesAmount`	-	USD	Annual
December 2014 public offering warrants exchange and common shares issuance, Amount	`December2014PublicOfferingWarrantsExchangeAndCommonSharesIssuanceAmount`	$322.00K	USD	Annual
Series B, Tranche A, warrant price adjustment	`SeriesBTrancheWarrantPriceAdjustment`	-	USD	Annual
Series B preferred stock exchange	`SeriesBPreferredStockExchange`	$-678.00K	USD	Annual
Series C preferred stock and warrant issuance, Amount	`SeriesCPreferredStockAndWarrantIssuanceAmount`	$3.01M	USD	Annual
Series C preferred stock exchanged for Series C1 preferred stock, Amount	`SeriesCPreferredStockExchangedForSeriesC1PreferredStockAmount`	-	USD	Annual
Issuance of common stock for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$50.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.01M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$95.00K	USD	Annual
Net Loss	`NetIncomeLoss`	$-3.97M	USD	Annual
Net Loss	`NetIncomeLoss`	$-6.90M	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$-4.46M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-5.56M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-9.27M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.